Sung Ming-Tse, Maclennan Gregory T, Lopez-Beltran Antonio, Montironi Rodolfo, Cheng Liang
Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Cancer. 2006 Dec 1;107(11):2622-7. doi: 10.1002/cncr.22311.
Inverted urothelial papilloma is an uncommon urothelial neoplasm. Although it is traditionally regarded as a benign tumor, conflicting data on multiplicity, recurrence rate, and association with urothelial carcinoma have left uncertainties concerning its biologic behavior.
The authors analyzed the clinicopathological characteristics of 75 cases of inverted papilloma in the urinary tract without prior or concurrent urothelial carcinoma to determine its biologic behavior and prognosis, and to correlate these findings with surveillance strategies.
These patients ranged in age from 26 to 85 years (mean, 60 years). Of the 46 patients for whom tobacco use history was available, 28 gave a history of smoking. Inverted papillomas were located in the urinary bladder (67 cases), prostatic urethra (4 cases), and ureter (4 cases). The majority of vesical tumors arose from the trigone or near the bladder neck. Common presenting complaints included hematuria, dysuria, and irritative voiding symptoms. In 1 case of vesical inverted papilloma, there was a recurrence. All other patients were free of tumor recurrence or progression during a mean follow-up of 68 months (range, 2-240 months).
Both the extremely low incidence of tumor recurrence (1%) and strikingly favorable prognosis suggest that inverted urothelial papilloma, when diagnosed according to strictly defined criteria, is a benign urothelial neoplasm not related to urothelial carcinoma. Therefore, complete transurethral resection of inverted papilloma is adequate surgical therapy, and surveillance protocols as rigorous as those employed in the management of urothelial carcinoma seem unnecessary.
内翻性尿路上皮乳头状瘤是一种罕见的尿路上皮肿瘤。尽管传统上认为它是良性肿瘤,但关于其多发性、复发率以及与尿路上皮癌的关联等相互矛盾的数据,使得其生物学行为仍存在不确定性。
作者分析了75例尿路内翻性乳头状瘤患者的临床病理特征,这些患者既往无尿路上皮癌,也无同时发生的尿路上皮癌,以确定其生物学行为和预后,并将这些结果与监测策略相关联。
这些患者年龄在26至85岁之间(平均60岁)。在有吸烟史的46例患者中,28例有吸烟史。内翻性乳头状瘤位于膀胱(67例)、前列腺尿道(4例)和输尿管(4例)。大多数膀胱肿瘤起源于三角区或膀胱颈附近。常见的症状包括血尿、排尿困难和刺激性排尿症状。1例膀胱内翻性乳头状瘤出现复发。在平均68个月(范围2至240个月)的随访期间,所有其他患者均无肿瘤复发或进展。
肿瘤复发率极低(1%)以及显著良好的预后均表明,按照严格定义的标准诊断的内翻性尿路上皮乳头状瘤是一种与尿路上皮癌无关的良性尿路上皮肿瘤。因此,经尿道完全切除内翻性乳头状瘤是足够的手术治疗方法,似乎没有必要采用像管理尿路上皮癌那样严格的监测方案。